Skip to main content
Premium Trial:

Request an Annual Quote

Genomenon, Inozyme Collaborate on MDx Effort for ENPP1 Deficiency

NEW YORK – Genomenon said Thursday that it has formed a partnership with Inozyme Pharma to deliver molecular diagnostic data on a rare pediatric-onset calcification disorder to testing laboratories and clinicians.

The collaboration aims to improve the diagnosis and treatment of ENPP1 deficiency, also known as generalized arterial calcification of infancy or autosomal recessive hypophosphatemic rickets Type 2.

Genomenon has applied its artificial intelligence to produce a variant dataset and companion lists of clinical trials and therapies for ENPP1 deficiency, which the Ann Arbor, Michigan-based company delivers to clinicians and researchers through its Mastermind genomic search engine. Boston-based Inozyme is developing therapies for the rare disease.

"Genomenon's collaboration with Inozyme Pharma represents a shared mission to ensure that no rare disease patient goes undiagnosed or untreated," Genomenon CEO Mike Klein said in a statement. "In the rare disease space, knowledge is power, and this effort will put critical information at the fingertips of doctors seeking diagnoses for their patients."

Inozyme cofounder and CEO Axel Bolte said that Genomenon's technology and dataset should improve understanding of the rare disorder. "We expect our collaboration will improve the speed and accuracy of the diagnostic journey for patients with ENPP1 deficiency by providing the data to them, their caregivers, and medical teams to make informed decisions about their disease, ongoing research, and clinical trials," Bolte said.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.